David Shaw’s Ascendis Pharma A/S ASND Stock Holding History

David Shaw’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.38M	Sell	31,400 -16,700	-35%	-$3.9M	﹤0.01%	1979
2026 Q1	$11M	Buy	48,100 +42,400	+744%	+$9.5M	0.01%	1550
2025 Q4	$1.22M	Buy	5,700 +700	+14%	+$145K	﹤0.01%	3412
2025 Q3	$994K	Hold	5,000	–	–	﹤0.01%	3466
2025 Q2	$863K	Hold	5,000	–	–	﹤0.01%	3323
2025 Q1	$779K	Hold	5,000	–	–	﹤0.01%	3244
2024 Q4	$688K	Hold	5,000	–	–	﹤0.01%	3428
2024 Q3	$747K	Buy	+5,000	New	+$675K	﹤0.01%	3470

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

David Shaw's ASND Position: Q2 2026 in Review

David Shaw increased its Ascendis Pharma A/S (ASND) stake by 2,808% in Q2 2026, buying an estimated $6.97M and bringing the position to 30,883 shares worth $8.24M. The position accounts for ﹤0.01% of the portfolio, ranked #1993.

David Shaw first reported a position in ASND in Q1 2018 and has held it in 34 quarters since. The position peaked at $51.4M in Q1 2024. 311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

David Shaw held 30,883 shares of Ascendis Pharma A/S worth $8.24M as of Q2 2026.
David Shaw bought 29,821 Ascendis Pharma A/S shares in Q2 2026, an estimated $6.97M.
Ascendis Pharma A/S made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #1993 holding.
David Shaw first reported a position in Ascendis Pharma A/S in Q1 2018 and has held it in 34 quarters since.
David Shaw's Ascendis Pharma A/S position peaked at $51.4M in Q1 2024.
311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.